Carl Ashley Morris - Mar 14, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Chief Scientific Officer
Signature
/s/ Erin P. Brennan as attorney-in-fact for Carl Ashley Morris
Stock symbol
SLDB
Transactions as of
Mar 14, 2022
Transactions value $
-$24,932
Form type
4
Date filed
3/15/2022, 05:14 PM
Previous filing
Jan 31, 2022
Next filing
May 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Sale -$12.4K -11.3K -4.06% $1.10 267K Mar 14, 2022 Direct F1, F2
transaction SLDB Common Stock Sale -$12.5K -11.4K -4.27% $1.10 255K Mar 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
F2 Includes 2,272 shares acquired by Mr. Morris under the Solid Biosciences Employee Stock Purchase Plan on November 30, 2021.